Skip to content

Pilates in patients with Persistent Pain

Pilates in patients with Chronic Pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2d2vb9
Enrollment
Unknown
Registered
2020-06-26
Start date
2020-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low back pain

Interventions

A sample will be used by individuals, both genders, allocated in two groups: 1) Pilates of low / moderate intensity (n = 66) and 2) high intensity (n = 66). All participants receive an exercise progra
Other
E02.760.169.063.500.387
M54.5

Sponsors

Faculdade de Medicina da Universidade Federal do Ceará
Lead Sponsor
Faculdade de Medicina da Universidade Federal do Ceará
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The study will include individuals aged between 18 and 60 years, of both sexes, who have had low back pain for more than 12 weeks.

Exclusion criteria

Exclusion criteria: Individuals contraindicated for therapeutic exercise, according to the Physical Activity Readiness Questionnaire, who underwent treatment with Pilates in the last 3 months, pregnant women, severe spinal pathologies (example: fracture, tumor, infection), previous spinal surgery and lower limbs, inflammatory, rheumatic or neurological disorders, nerve root involvement, osteoporosis, inability to understand written or spoken Portuguese and who has received physical therapy in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: improvement in functional disability. This will be assessed using the Roland-Morris Disability Questionnaire. It consists of a questionnaire with 24 questions related to activities of daily living (ADLs). Each affirmative answer is equivalent to 1 point, obtaining the final result through the sum of these. The higher the score, the greater the individual's disability. It will be evaluated at baseline and after 6 weeks of intervention.;Expected outcome 2: lower back pain. This will be assessed using the Numerical Pain Scale. It consists of a scale from 0 to 11, with 0 being “no pain” and 10 “the maximum possible pain”. Participants will be asked to rate their pain according to the past 7 days. It will be evaluated at baseline and after 6 weeks of intervention.

Secondary

MeasureTime frame
Expected outcome 1: improvement in specific disability. This will be assessed through the Patient Specific Functional Scale. It consists of the identification of three difficult or impossible activities to be performed due to low back pain. Each activity will be classified on a scale from 0 to 11, with 0 being “unable to perform the activity” and 11 “capable of performing the activity at the pre-injury level”. The final score is given by averaging these three ratings and the higher the score, the greater the specific disability. It will be evaluated at baseline and after 6 weeks of intervention.;Expected outcome 2: reduction of kinesiophobia. This will be assessed through the Tampa Scale for Kinesiophobia. It consists of a 17-item questionnaire. Each item has four possible answers: 1 point for "strongly disagree", 2 points for "partially disagree", 3 points for "partially agree" and 4 points for "strongly disagree". The final score can vary from 17 to 68 points and the higher the score, the greater the degree of kinesiophobia. It will be evaluated at baseline and after 6 weeks of intervention.;Expected outcome 3: increase in isometric muscle strength of the hip. This will be assessed using the Hand-Held Dynamometer using the hip stability isometric test (HipSIT). The test was created to assess the strength of the hip in a three-dimensional way, so that it evaluates abductors, external rotators and hip extensors together. It will be evaluated at baseline and after 6 weeks of intervention.

Countries

Brazil

Contacts

Public ContactAnita Coelho

Universidade Federal do Ceará (UFC)

anitafisioterapia@hotmail.com+55-085-999336239

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 4, 2026